An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection
Disease Models & Mechanisms · 01.09.2025 · 18 (9)
DOI: 10.1242/dmm.052085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 01.08.2025. Verfasst von Victoria Ektnitphong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Y9.308, Dallas, TX 75390-9113, USA. Hauptthemen laut MEDLINE: Mycobacterium fortuitum, Mycobacterium Infections, Nontuberculous, Lab-On-A-Chip Devices, Pulmonary Alveoli. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Lung disease due to non-tuberculous mycobacteria (NTM) is rising in incidence. Although both two-dimensional cell culture and animal models exist for NTM infections, a major knowledge gap is the early responses of human alveolar and innate immune cells to NTM within the human alveolar microenvironment. Here, we describe the development of a humanized, three-dimensional, alveolus lung-on-a-chip (ALoC) model of Mycobacterium fortuitum lung infection that incorporates only primary human cells, such as pulmonary vascular endothelial cells, in a vascular channel, and type I and II alveolar cells and monocyte-derived macrophages in an alveolar channel along an air–liquid interface. M. fortuitum introduced into the alveolar channel primarily infected macrophages, with rare bacteria inside alveolar cells. Bulk RNA sequencing of infected chips revealed marked upregulation of transcripts for cytokines, chemokines and secreted protease inhibitors (SERPINs). Our results demonstrate how a humanized ALoC system can identify critical early immune and epithelial responses to M. fortuitum infection. We envision potential application of the ALoC to other NTM and in studies of new antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Y9.308, Dallas, TX 75390-9113, USA.
- Department of Microbiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Y9.308, Dallas, TX 75390-9113, USA.
ORCID-Profile: Victoria Ektnitphong, Beatriz R S Dias, Priscila C Campos, Michael U Shiloh
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- University of Texas Southwestern Medical Center
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ektnitphong, V., Dias, B. R. S., Campos, P. C., & Shiloh, M. U. (2025). An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection. Disease Models & Mechanisms, 18(9). https://doi.org/10.1242/dmm.052085
Vancouver
Ektnitphong V, Dias BRS, Campos PC, Shiloh MU. An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection. Disease Models & Mechanisms. 2025;18(9). doi:10.1242/dmm.052085
BibTeX
@article{Ektnitphong2025,
author = {Ektnitphong, Victoria and Dias, Beatriz R S and Campos, Priscila C and Shiloh, Michael U},
title = {An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection},
journal = {Disease Models & Mechanisms},
year = {2025},
volume = {18},
number = {9},
doi = {10.1242/dmm.052085}
}
EUVIMED